Related Experiment Video
Updated: May 21, 2026
09:28
One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
Published on: June 25, 2010
Newborn metabolic screening and related pitfalls
1Division of General Academic Pediatrics, Saint Louis University School of Medicine, Cardinal Glennon Children's Medical Center, USA.
Missouri Medicine
|May 31, 2012
Summary
Newborn screening now uses advanced technology for early disease detection. This review covers new lab capabilities and challenges in interpreting results for vulnerable infants.
Area of Science:
- Biochemistry
- Medical Diagnostics
- Public Health
Background:
- Advances in understanding medical disorders have improved newborn screening.
- Newborn screening is crucial for early detection and management of congenital conditions.
Purpose of the Study:
- To review the enhanced capabilities of the Missouri State Newborn Screening Laboratory.
- To identify challenges in interpreting newborn screening results.
Main Methods:
- Tandem mass spectrometry implementation in 2005.
- Review of screening protocols and result interpretation.
Main Results:
- Enhanced detection capabilities for various metabolic disorders.
- Identification of confounding factors affecting screening accuracy.
Conclusions:
- Newborn screening has significantly advanced with new technologies.
- Careful interpretation is needed for preterm infants or those receiving transfusions/fluids.
Related Concept Videos
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...